Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation.

Cheng-Maw HoRey-Heng HuYao-Ming WuMing-Chih HoPo-Huang Lee

Published in: Clinical Medicine Insights. Oncology (2020)

Additional large-scale studies are required to validate positive cross-match as an immuno-oncological factor associated with HCC recurrence and inferior patient survival.

Keyphrases

free survival
rectal cancer
radical prostatectomy
robot assisted
case report
prostate cancer
case control
minimally invasive